The article discusses the initiative taken by federal government to establish Drug Regulatory Authority of Pakistan (DRAP) which manage and regulate pharmaceutical trade and industry in Pakistan. Topics discussed include the affect of increasing fees and charges by DRAP on drugs exports, eligibility ...
Drug regulation has been identified as a crucial impediment to the progress of Pakistan's health sector, particularly in the wake of the 'Fake Drug Crisis' of 2012. In 2010, control of the Drug Regulatory Authority of Pakistan (DRA), shifted from the federal government to provincial governments...
13. Pakistan:http://www.dcomoh.gov.pk/ 14. Qatar:http://www.nha.org.qa/moh / under construction 15. Saudi Arabia:http://www.sfda.gov.sa/En/Home/default.htm 16. Somalia: no website identified 17. Sudan:http://www.nmpb.gov.sd/ 18. Syrian Arab Republic: no website identified 19...
Post-marketing reporting of ADRs is a legal requirement. All serious or suspected ADRs must be reported to the regulatory authority by the medicine licence holder or applicant within 15 days of receipt of such information [46]. There are also initiatives among the provinces (regions) to promote...
Pharmaceutical Marketing Codes of Ethics Ethical Promotion Drug Regulations Regulatory FrameworksThis paper elucidates the current achievements of the Drug Regulatory Authority of Pakistan (DRAP) in the ethical promotion of medicines. The old orthodoxy of mMalik, Fazal...